Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection.
Gaipa G, Basso G, Maglia O, Leoni V, Faini A, Cazzaniga G, Bugarin C, Veltroni M, Michelotto B, Ratei R, Coliva T, Valsecchi MG, Biondi A, Dworzak MN; I-BFM-ALL-FCM-MRD Study Group.
Gaipa G, et al. Among authors: biondi a.
Leukemia. 2005 Jan;19(1):49-56. doi: 10.1038/sj.leu.2403559.
Leukemia. 2005.
PMID: 15538405
Clinical Trial.